retatrutide clinical trial malaysia New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Looking forward to when #retatrutide's

current studies are often constrained by small cohorts, short durations, and inconsistent formulations, limiting their reproducibility and translational relevance (Vauzour et al

But theres a catch: a lot of people make simple mistakes that water down their results

Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial

This is called glossitis

Through California Trim Clinics nationwide telehealth program, licensed providers review your health history and wellness goals to determine whether compounded peptide therapy may be appropriate for you

Here, we discuss results from Wave 12, conducted in February 2025